Induction Chemoterapy With Folfoxiri Plus Cetuxumab in Unresectable Colorectal Cancer Patient

NCT02295930 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

143

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

OTHER: folfoxiri+cetuximab+surgery+cetuximab
OTHER: folfoxiri+cetuximab+surgery+bevacizumab

Sponsor

Gruppo Oncologico del Nord-Ovest